bionics certificate

Click here to load reader

Post on 24-Oct-2021




0 download

Embed Size (px)


Bionics presentation Innovations in the fields of medicine, artificial intelligence, robotics and sensors are finally giving a
new life to medical technologies and are making human enhancement a reality
Bionics, which is taking on human body dysfunctions and disabilities and, more globally, helping
improve the wellness and lifespan of the world population, benefits from long-term drivers:
an ageing world population and a shortage of donated organs
major technology breakthroughs leading to an impressive product pipeline
an improving outlook for the reimbursement of bionic devices by insurers or health agencies
Bionics is not only about next-gen prosthetics, it also covers artificial organs, wearable devices,
surgical and medical robots, synthetic biology, biotechnology and artificial intelligence
Bionics Certificate details
ISIN: XS1317063912
Currency: USD
Fees: 1.65% management fee + 15% performance fee, high water mark
Bloomberg ticker: NXSRBION
Leveraging on Life mechanismsFixing our body dysfunctions
Replacing limbs and organs Using them for specific purposes
In particular for surgery Monitoring metabolism
Seconding humans Improving health
Bionics Certificate
According to the UN, the population aged 60 years or over will grow from 962M in 2017 to 2.1Bn in
2050, while the population >80 years old will grow from 137M to 425M
The bulk of the growth comes from Asia: 66% growth of people >60 years old
has a disability
waiting for lifesaving
Medical technology innovations are made possible thanks to advances in:
Research is performed on extending Moore’s Law by optimizing chip technology
Quantum computing will further extend Moore’s law exponentially
Bionics Certificate
The price of bionic devices has been unsurprisingly high until now (between $50,000 and $150,000
for an eye or limb device and surgery)
Encouragingly, coverage by Medicare in the US seems to be heading in the right direction
…But Likely To Gradually Expand As Benefits Outweigh Declining Costs
Declining costs and social welfare: a major catalyst for expanded health coverage
some of the technologies used will mature over the years and become less costly
a bionic device can allow people to keep working and return to work more quickly
Health Coverage Of Bionic Devices Has Been An issue…
Bionics Certificate
CAGR 17-23
A $113B MARKET BY 2023
Bionics Certificate
Bionics Certificate
Synthetic biology is the engineering of biology: the synthesis of complex, biologically based
systems which display functions that do not exist in nature
While products that utilize synthetic biology are yet to be commercialized, this market is set to
literally explode in the next few years driven by demand for improved drugs and vaccines
Key constraints are mostly ethics and bio-security/safety, as synthetic biology can be misused
Bionics Certificate
Telemedicine Robots
Rehabilitation robots, exoskeletons
Bionics Certificate
The first artificial organ was designed in 1943 to replace a deficient kidney: a dialyzer
the bionic man Bertolt Meyer designed in 2013
Bionics Certificate
autonomous, dual-hormone system
The Zephyr BioPatch: a FDA-
cleared small device monitoring
Medical Wearable Devices: An Important Link In The Chain
Prosthetics are now on their way to offering real limb replacement…
A cochlear implant does the work of damaged parts of the inner ear…
A bionic eye complements impaired retinas…
Sensors deliver electrical signals to the nervous system, enabling the brain to feel / hear / see
Bionics Certificate
Bionics Certificate
This report has been produced by the organizational unit responsible for investment research (Research
unit) of AtonRâ Partners and sent to you by the company sales representatives.
As an internationally active company, AtonRâ Partners SA may be subject to a number of provisions in
drawing up and distributing its investment research documents. These regulations include the Directives
on the Independence of Financial Research issued by the Swiss Bankers Association.
Although AtonRâ Partners SA believes that the information provided in this document is based on reliable sources, it cannot assume responsibility for the quality, correctness, timeliness or completeness of the information contained in this report.
The information contained in these publications is exclusively intended for a client base consisting of professionals or qualified investors. It is sent to you by way of information and cannot be divulged to a third party without the prior consent of AtonRâ Partners.
While all reasonable effort has been made to ensure that the information contained is not untrue or misleading at the time of publication, no representation is made as to its accuracy or completeness and it should not be relied upon as such.
Past performance is not indicative or a guarantee of future results. Investment losses may occur, and investors could lose some or all of their investment.
Any indices cited herein are provided only as examples of general market performance and no index is directly comparable to the past or future performance of the Certificate.
It should not be assumed that the Certificate will invest in any specific securities that comprise any index, nor should it be understood to mean that there is a correlation between the Certificate’s returns and any index returns.
Any material provided to you is intended only for discussion purposes and is not intended as an offer or solicitation with respect to the purchase or sale of any security and should not be relied upon by you in evaluating the merits of investing in any securities.

View more